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Abstract
Objective: MicroRNAs (miRNAs) are small endogenous non-coding regulatory RNAs that 
control mRNAs post-transcriptionally. Several mouse stem cells miRNAs are cloned dif-
ferentially regulated in different hematopoietic lineages, suggesting their possible role in 
hematopoietic lineage differentiation. Recent studies have shown that specific miRNAs 
such as Mir-451 have key roles in erythropoiesis.
Materials and Methods: In this experimental study, murine embryonic stem cells (mESCs) 
were infected with lentiviruses containing pCDH-Mir-451. Erythroid differentiation was as-
sessed based on the expression level of transcriptional factors (Gata-1, Klf-1, Epor) and 
hemoglobin chains (α, β, γ , ε and ζ) genes using quantitative reverse transcriptase-poly-
merase chain reaction (qRT-PCR) and presence of erythroid surface antigens (TER-119 
and CD235a) using flow cytometery. Colony-forming unit (CFU) assay was also on days 
14th and 21th after transduction.        
Results: Mature Mir-451 expression level increased by 3.434-fold relative to the untreated 
mESCs on day 4 after transduction (P<0.001). Mir-451 up-regulation correlated with the induc-
tion of transcriptional factor (Gata-1, Klf-1, Epor) and hemoglobin chain (α, β, γ, ε and ζ) genes 
in mESCs (P<0.001) and also showed a strong correlation with presence of CD235a and Ter-
119 markers in these cells (13.084- and 13.327-fold increse, respectively) (P<0.05). Moreover, 
mESCs treated with pCDH-Mir-451 showed a significant raise in CFU-erythroid (CFU-E) colo-
nies (5.2-fold) compared with untreated control group (P<0.05).                 
Conclusion: Our results showed that Mir-451 up-regulation strongly induces erythroid differen-
tiation and maturation of mESCs. Overexpression of Mir-451 may have the potential to produce 
artificial red blood cells (RBCs) without the presence of any stimulatory cytokines.      
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Introduction
Embryonic stem cells (ESCs) are multipotent 
stem cells derived from the inner cell mass of the 
blastocyst, an early-stage embryo (1-3). ESCs keep 
pluripotency and self-renewing ability due to both 
their inherent properties and the culture conditions 
in which they are grown (2). The significance of 
ESCs in modern biology and medicine derives 
from two unique characteristics that differenti-
ate them from all other organ-specific stem cells 
identified to date. First, they can be maintained 
and enlarged as pure populations of undifferenti-
ated cells for extended periods of time, possibly 
indefinitely, in culture (3). Secondly, they show 
a remarkable capacity to form differentiated cell 
types in culture (4). A close relationship between 
microRNAs (miRNAs) and ESC development has 
been observed (5, 6).
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Erythropoiesis is the complex process through 
which a fraction of primitive multipotent hematopoi-
etic stem cells (HSCs) convert to the committed red 
cell lineage, undergoing differentiation to erythroid 
progenitors [burst forming unit-erythroid (BFU-E) 
and colony-forming unit-erythroid (CFU-E)], nor-
moblasts, erythroblasts, reticulocytes, and ultimately 
mature erythrocytes (7). This process is regulated by 
many factors including erythropoietin, testosterone, 
estrogen, interleukin-3 (IL-3), granulocyte-mac-
rophage colony-stimulating factor, IL-9, transcrip-
tional networks and miRNAs (8, 9).
MiRNAs are small endogenous non-coding RNA 
molecules (19 to 25 nts) that regulate gene expression 
post-transcriptionally (10) and are phylogenetically 
conserved (5, 11). While some miRNAs are stead-
ily expressed in the whole organism, their expression 
pattern is often temporal and/or tissue-specific (12-
14). MiRNAs can play significant roles in growth by 
targeting the transcripts of protein-coding genes and 
suppressing productive translation (15-17). MiRNAs 
have shown to be involved in many different cellular 
processes including metabolism, apoptosis, differen-
tiation, and development (15). Many miRNAs are 
implicated in a variety of developmental and physi-
ological processes (18, 19). Expression profile of 
miRNAs in the course of hematopoietic development 
suggested their potential involvement in hematopoi-
etic differentiation regulation (20, 21). The HSCs lead 
to both myeloid and lymphoid progenitors (21, 22).
MiRNAs may create a regulatory network with 
cytokines and transcriptional factors to control eryth-
roid lineage commitment and differentiation (23). Of 
note, Mir-451 exists in mature circulating red blood 
cells (24, 25). Any expression changes of Mir-451 
in murine erythroleukemia (MEL) cells promoted or 
impaired erythrocyte differentiation, respectively (23, 
26). Gata Binding Protein 1 (Globin Transcription 
Factor 1) [Gata-1] is a hematopoietic transcription 
factor essential for the production of erythrocytes, eo-
sinophils, platelets and mast cells (27). Gata-1 organ-
izes erythropoiesis by inducing and repressing genes 
involved in cell division, apoptosis, and terminal 
maturation (28). Gata-1 indorses erythroid-specific 
gene expression through binding at regulatory ele-
ment sites within the promoters of α- and β-globin and 
other erythroid-specific genes (29). Erythropoietin 
receptor (Epor) can induce proliferation of cultured 
chicken, mouse and human erythroid progenitors. 
Damaged signaling from the Epor not only affects 
stress erythropoiesis, but also causes erythropoiesis 
defects during normal development (30). Erythroid 
Kruppel-like factor (Eklf) (a.k.a. Klf1) is a red cell-
enriched DNA binding protein that cooperates with 
its cognate 5´-CCMCRCCCN-3´element within tar-
get promoters and enhancers. In genetic, biochemi-
cal and molecular studies, the role of Klf1 in β-like 
globin gene regulation has been emphasized since its 
discovery (31). Klf1 is a key erythroid transcriptional 
regulator (32, 33) and induces a different set of genes 
associated with erythropoiesis including the β-globin 
gene (Hbb) (34).
In this experimental study, we examined the early 
stages of mESCs lineage commitment by investi-
gating whether Mir-451 up-regulation could induce 
erythropoiesis differentiation from mESCs and be 
used as a replacement to the stimulatory cytokines 
for mESCs differentiation into erythroid cells.
Materials and Methods
HEK-293T cell line culture
Human embryonic kidney (HEK)-293T cell 
line was obtained from the National Cell Bank of 
Iran (Pasteur Institute, Iran). The HEK-293T cells 
were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM), 10 % fetal bovine serum (FBS), 
100 U/ml penicillin, 2 mM L-glutamine and 100 
µl streptomycin (all from Gibco, USA). This cell 
line was kept at 37˚C in a humidified atmosphere 
containing 95 % humidity and 5 % CO2 according 
to the supplier’s instructions.
Recombinant lentiviruses production 
The pCDH-451 plasmid was produced by li-
gating 250 bp fragments encompassing pri- Mir-
451  sequences into the XbaI /BamHI restriction 
sites of the pCDH-CMV-MCS-EF1-copGFP vec-
tor (System Biosciences, USA). These fragments 
were elevated by polymerase chain reaction (PCR) 
reaction using following primers: pri- Mir-451  F: 
5′-GTC GTA TGC AGA GCA GGG TCC GAG 
GTA TTC GCA CTG CAT ACG ACA ACT CA-
3′ and R: 5′- GTCGTATGCAGAGCAGGGTC-
CGAGGTATTCGCACTGCATACGACAAC-
CTC-3′ on extracted genomic DNA. For lentivirus 
production; HEK-293T cells (3×106) were seeded 
into 10-cm plates containing DMEM medium sup-
plemented with 10% FBS. The day after, pPAX2 
plasmid (containing gag and pol genes) and pMD2 
plasmid (containing vsv gene) were co-transfected 
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with the pCDH-451 plasmid empty vector (pCDH 
empty backbone) as negative control into seeded 
HEK-293T cells using the lipofectamin 2000 reagent 
(Invitrogen, USA) according to the manufacturer’s 
protocol. The supernatants containing generated lenti-
viruses were collected every 12 hours for 3 days after 
transfection and concentrated by ultracentrifugation 
at 40.000 g for 2 hours. Then for virus titration, HEK-
293T cells were transduced with a different concen-
tration of recombinant lentiviruses and the number 
of viruses in the functional copy was detected using 
green fluorescent protein (GFP) protein and fluores-
cent microscope forty-eight hours later.
Murine embryonic stem cells culture 
Murine ESC (mESC) [E14Tg2A] lines were cul-
tured on gelatin-coated tissue culture dishes (Sigma, 
USA) at an intensity of 40,000 cells/cm2. ESC medi-
um, which was exchanged daily, contained knockout 
DMEM, 20% FBS-ES,1 mM sodium pyruvate (Gib-
co, USA), 2 mM Glutamine (Euroclone, Italy), 0.05 
mM b-mercaptoethanol, 1 mM non-essential amino 
acids (Gibco, USA), 1,000 U/ml recombinant mouse 
leukemia inhibitory factor ( LIF, Sigma, USA) and 
100 U/ml penicillin/streptomycin (Euroclone, Italy).
Murine embryonic stem cells infection 
The infection was done in three groups. Each 
groups had three samples. Embryonic bodies (EB) 
were cultured for 1 to 21 days under the following 
conditions: i. Blank: EBs did not receive any treat-
ment (untreated group), ii. pCDH-451 lentiviruses: 
EBs were transduced with pCDH-451 lentiviruses 
(pCDH-451 group) and iii. pCDH-empty lentivi-
ruses: EBs were transduced with pCDH-empty 
lentiviruses (negative control group).
After 14 and 21 days, the effect of Mir-451 up-
regulation in erythroid differentiation was moni-
tored by analyzing expression of transcriptional 
factor (Gata-1, Klf-1 and Epor) and hemoglobin 
chain (α, β, γ, ε and ζ) using quantitive reverse 
transcriptase- PCR (qRT-PCR) and presence of 
erythroid cell surface markers (CD235a and Ter-
119) using flow cytometry.
RNA extraction  
Total RNA was extracted from test and control 
groups using the Trizol reagent (Gibco, USA), ac-
cording to the manufacturer’s instructions. cDNA 
was synthesized by Superscript II reverse transcrip-
tion (Invitrogen, USA) and random hexamer primers, 
according to the manufacturer’s instructions.
Real-time reverse transcriptase-polymerase 
chain reaction quantification of miRNAs  
Real-time RT-PCR quantification of miRNAs 
was undertaken using primers designed Primer 
Express version 2.0 (Applied Biosystems, Foster 
City, CA). Briefly, first cDNA strand was synthe-
sized through miRNA 1st-strand cDNA synthesis 
kit (Stratagene, USA) and reverse transcribed into 
qPCR-ready cDNA. After that, miRNA qRT-PCR 
was carried out in triplicate on ABI PRISM 7500 
real time PCR System (Applied Biosystems, USA) 
with the high-specifity miRNA qPCR core reagent 
kit (Stratagene, USA) and normalized to U6 small 
nuclear RNA (Snord47) as an endogenous control. 
Primer sequences are shown in Table 1. The qRT-
PCR cycling conditions were 10 minutes at 95˚C 
followed by 40 cycles of 10 seconds at 95˚C, 15 
seconds at 60˚C, and 20 seconds at 72˚C. Data 
analyses were performed using the 2−ΔΔct method.
Table 1: The sequence of primers that used in this study
Primer (5´-3´)Gene
F: CGA GAA ACC GTT ACC ATT AC
R: GAG CAG GGT CCG AGG T
Mir-451
F: ATC ACT GTA AAA CCG TTC CA
R: GAG CAG GGT CCG AGG T
Snord47 
F: CAC  TCC  CCA  GTC  TTT  CAG  G
R: TGC  CGT  CTT  GCC  ATA  GG
Gata-1
F: CGC  ACA  CGG  GAG  AGA  AG
R: ACA  GCA  GAA  GGG  ACG  ATG
Klf-1
F: ATA  TCA  ATG  AAG  TAG  TGC  TCC  TG
R: CCC  TTT  GTG  TCC  CTC  CTG
Epor
F: CAA  CTT  CAA  GCT  CCT  GTC  C
R: GGA  GGG  TTC  AAT  AAA  GGG
ζ chain
F: GGG  AAG  GCT  CCT  GAT  TG
R: CAC  TGA  GAT  GAG  CAA  AGG TC
ε chain
F: AAC  TTC  AAA  CTC  TTG  GGT  AAT  G
R: GGA  GGC  ATA  GCG  GAC  AC
γ chain
F: CTG  ATT  CTG  TTG  TGT  TGA  CTT  G
R: GAC  AAC  CAG  CAG  CCT  GC
β chain
F: CTG  GAA  AGG  ATG  TTT  GCT  AG
R: CAT  CGG  CGA  CCT  TCT  TG
α chain
F: CTT CTT GGG TAT GGA ATC CTG 
R: GTG TTG GCA TAG AGG TCT TTA C
β.actin
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Real-time reverse transcriptase-polymerase 
chain reaction quantification of transcriptional 
factors and hemoglobin chains  
Expression of transcriptional factor (Gata-1, Klf-
1, Epor) and hemoglobin chain (α, β, γ , ε and ζ) 
genes was quantified using ABI PRISM 7500 re-
al-time PCR System (Applied Biosystems, USA) 
with the SYBR premix ExTaq kit (Takara, Japan) 
according to the manufacturer’s instruction. The 
qRT-PCR cycling conditions were done same as 
above.
Flow cytometry  
Cells from all groups (blank control group, 
pCDH-451 group and negative control group) 
were collected for flow cytometry. The viability of 
the cells was examined by trypan blue exclusion 
and was always greater than 95%. They were im-
munostained with phycoerythrin (PE)–conjugated 
anti-TER119 (1:200) and PE–conjugated anti-
CD235a (1:200, BD Pharmingen, San Diego, CA, 
USA) antibodies. Propidium iodide was added to 
exclude dead cells from analysis. The cells were 
then analyzed on flow cytometer PartecPAS III 
(Partec, Germany).
Colony-forming unit assays  
Colony-forming cell (CFC) assay was carried 
out in triplicate using methylcellulose complete 
media (MethoCultTM, StemCell Technologies, 
Inc, USA) according to the manufacturer’s in-
structions. In all groups, 5×103 mESCs were 
cultured in 35-mm plates with the medium con-
taining 25% FBS, 2% bovine serum albumin, 
1.3% methyl cellulose, 0.05 mmol/L 2-mer-
captoethanol, 3 U/mL erythropoietin (EPO), 2 
mmol/L L-glutamine, 50 ng/mL stem cell fac-
tor (SCF), 10 ng/mL IL-3 and 10 ng/mL granu-
locyte macrophage-colony-stimulating factor 
plus activin A (25 ng/mL). After incubation at 
37˚C, 5% CO2 and 95% humidity for 12 days, 
the colony-forming unit-granulocyte, erythroid, 
macrophage, megakaryocyte (CFU-GEMMs), 
colony-forming unit-granulocyte, macrophage 
(CFU-GMs) and CFU-Es in every dishes was 
sorted and counted under a high-quality invert-
ed microscope (Leica, Heidelberg, Germany).
Statistical analysis  
All tests were repeated three times and data were 
shown as mean ± SD. The comparison between 
groups was performed using the Student’s t test. 
P value less than 0.05 was considered statistically 
significant.
Results
Transfection efficiency and production of 
lentiviruses in HEK293T cells
The pMD2G, psPAX2 and pCDH-451 plasmids 
were co-transfected into HEK293T cells on a 10 cm 
plate using lipofectamin 2000 reagent (Invitrogen, 
USA) according to the manufacturer’s protocol 
(pCDH-451). Lentiviruses expressing Mir-451 
was then generated.
Lentiviral vectors created from pCDH-empty 
plasmids were used as negative control (pCDH-
Neg). Transfection efficiency was confirmed 
each time by fluorescent microscopy. Approxi-
mately 95% of cells in the pCDH-451 group and 
97% of cells in the pCDH-empty vector group 
with green fluorescence were distinguished 48 
and 72 hours after infection (Figs.1, 2). No flu-
orescent-positive cell was present in our control 
group.
Transduction efficiency and Mir-451 expression in 
murine embryonic stem cells 
In order to enter mESCs into erythroid com-
mitment, mESCs were transduced with lentivi-
ral vector pCDH-451 expressing copGFP and 
allowed to form EBs in suspension culture. 
CopGFP serves as an internal control by mark-
ing all cells that receive the vector. The con-
centrations of this vector was in the range of 
3×107 to 7×107 viral particles per milliliter and 
diverse multiplicities of infection were used to 
optimize transduction conditions. Transduction 
efficiency was monitored each time by fluores-
cent microscopy and evaluated by flow cytom-
etry for the GFP marker. GFP overexpression 
of lentiviruses in mESCs was 60% of cells with 
pCDH-451 and 65% of cells with pCDH-empty 
vectors and was distinguishable 96 hours after 
infection. No fluorescent-positive cell was de-
tected in our control group (Fig.3). 
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Fig.1: A. Transfected HEK293T cells examined by light microscopy and B. Transfected HEK293T cells examined by fluorescent microscopy. 
Transfection efficiency of murine embryonic stem cells (mESCs) with pCDH-Mir-451 was more than 95% as determined by fluorescent 
microscopy.
Fig.2: A. Transfected HEK293T cells examined by light microscopy and B. Transfected HEK293T cells examined by fluorescent microscopy. 
Transfection efficiency of murine embryonic stem cells (mESCs) with pCDH-empty vector was more than 95% as determined by fluores-
cent microscopy.
A B
A B
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Fig.3: A. Transduced murine embryonic stem cells (mESCs) examined 
by light microscopy and B. Transduced mESCs examined by fluo-
rescent microscopy. Transduction efficiency of mESCs with pCDH-
Mir-451 was more than 60% as determined by flow cytometry for 
the GFP marker.
Recombinant lentiviruses increased mature 
miRNAs level in treated murine embryonic 
stem cells 
We determined the expression level of Mir-451 on 
day 4 after transduction in test and control groups by 
qRT-PCR. In mESCs treated with pCDH-Mir-451 
lentiviruses, mature Mir-451 expression level in-
creased by 3.434-fold relative to the untreated mESCs 
(P<0.001, Fig.4). As expected, when mESCs were 
treated with pCDH-empty lentiviruses, mature Mir-
451 expression level displayed no significant altera-
tion compared with blank control groups (P>0.05). 
These results suggested that pCDH-Mir-451 recom-
binant lentiviruses are efficient and increased mature 
Mir-451 level significantly. 
Fig.4: Expression analysis (fold changes) of Mir-451 in treated 
murine embryonic stem cells (mESCs) on day 4. The expression 
of Mir-451 in the mESCs treated with pCDH-Mir-451 cells was 
significantly higher than that in mESCs treated with pCDH-empty 
vector and those untreated. Relative miRNA expression levels 
were normalized to Snord47 as an internal control. Columns, 
mean of three different experiments. *; P<0.001 and #; Results 
were compared with these columns.
Expression analysis of transcriptional factor genes 
We then examined the effect of this up-regulation 
on the expression of erythroid specific markers 
(Gata-1, Klf-1 and Epor) by qRT-PCR on day 14 
and 21, as an index of erythropoiesis. According to 
qRT-PCR results, the expression of these transcrip-
tional factors distinguished the pCDH-451, indicat-
ing successful erythropoeisis (Fig.5). In the mESCs 
treated with pCDH-Mir-451, Gata-1 and Klf-1 ex-
pression were increased by 1.952- and 4.084-fold, 
respectively when compared with the untreated con-
trol group on day 14 (P<0.001) but was decreased 
by 0.712- and 2.454-fold, respectively on day 21 
(P<0.001). In this group, Epor expression was in-
creased on day 14 and 21. Treatment of mESCs 
with pCDH-Mir-451 lentiviruses, led to the rise of 
Epor expression by 23.183-fold relative to the un-
treated mESCs on day 21 (P<0.001).
A
B
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Expression analysis of hemoglobin chain genes  
The expression profile of hemoglobin chain 
genes was obtained using qRT-PCR method on 
days 14 and 21. According to the qRT-PCR re-
sults, mESCs treated with pCDH-Mir-451 led to 
a significant increase of ε, ζ, γ and α transcripts 
(by 2.824-, 1.421-, 2.566- and 1.918-fold, respec-
tively) compared with the untreated control group 
on day 14 (P<0.05). On day 21, sharp increase 
of accumulation of ε, α and β-globin transcripts 
were detected in the pCDH-451 group (by 18.126-
, 14.774- and 25.723-fold, respectively) compared 
with the untreated control group (P<0.05). A moder-
ate increase of ζ transcripts (by 2.035-fold) was seen 
in mESCs treated with  pCDH-Mir-451 on day 21 
(P<0.05). The pattern of γ transcripts was decreased 
in this group (by 0.742-fold) compared with the un-
treated control group (P>0.05). These results further 
confirmed that  Mir-451 may have a vital roles in the 
induction of hemoglobinization (Fig.6).
Fig.5: A. Expression analysis (fold changes) of transcriptional factors in treated murine embryonic stem cells (mESCs) on day 14 and B. 
Expression analysis (fold changes) of transcriptional factors in treated mESCs on day 21. Relative transcriptional factors expression levels 
were normalized to β-Actin  as an internal control. Results presented as fold change compared with the control group. Columns, mean of 
three different experiments. *; P< 0.001 and #; Results were compared with these columns.
Fig.6: A. Expression analysis (fold changes) of hemoglobin chains in treated murine embryonic stem cells (mESCs) on day 14 and B. Ex-
pression analysis (fold changes) of hemoglobin chains in treated mESCs on day 21. Relative hemoglobin chains expression levels were 
normalized to β-Actin  as an internal control.  Results presented as fold change compared with the control group. Columns, mean of three 
different experiments. *; P<0.05 and #; Results were compared with these columns.
A B
A B
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Flow cytometry analysis of TER-119 and 
CD235a expressions  
As other indicators of erythropoiesis, the pres-
ence of TER119 and CD235a was estimated using 
flow cytometry on days 14 and 21. As shown in 
Table 2, in the pCDH-451-infected group, over-
expression of Mir-451 led to a rise in the pro-
portion of cells expressing TER119 and CD235a 
30.12 ± 2.34% for and 17.47 ± 2.21%, respec-
tively, compared with 3.87 ± 0.95% and 2.56 ± 
0.87% of the control cells (untreated mESCs), 
respectively, on day 14 (7.782- and 6.824-fold, 
respectively, P<0.05). Results on day 21 showed 
the percentage of cells positive for TER119 and 
CD235a was 66.34 ± 2.81% and 46.38 ± 2.37% 
in Mir-451 treated mESCs and  5.07 ± 1.01% and 
3.48 ± 1.28% in untreated mESCs, respectively 
(13.084- and 13.327-fold, respectively, P<0.05) 
(Figs.7, 8).  
Colony-forming unit assays
On the 12th day after incubation, the cells in 
the three groups created three types of colonies, 
indicating their ability to develop different pro-
genitor cells (Fig.9). The number of Mir-451 in 
treated mESCs, pCDH-empty vector and untreated 
mESCs in treated-formed colonies, CFU-E, CFU-
GM, and CFU-GEMM colonies are shown in Table 
3. According to CFU assay results, mESCs treated 
with pCDH-Mir-451 led to a significant increase in 
CFU-E colonies (by 5.2-fold) compared with the 
untreated control group (P<0.05).
Table 2: The proportion of cells expressing TER119 and CD235a in three mESCs groups by FACS 
Day 21Day 14Groups
The proportion of the cells expressing TER119
66.34 ± 2.81%30.12 ± 2.34%Treated mESCs with Mir-451
7.90 ± 1.41%4.02 ± 1.21%Treated mESCs  with pCDH-empty
5.07 ± 1.01%3.87 ± 0.95%Untreated mESCs
The proportion of the cells expressing CD235a
46.38 ± 2.37%17.47 ± 2.21%Treated mESCs with Mir-451
6.0 3 ± 1.19%2.98 ± 1.36%Treated mESCs with pCDH-empty
3.48 ± 1.28%2.56 ± 0.87%Untreated mESCs
 mESCs; Murine embryonic stem cells. 
Table 3: Colony-forming ability of Mir-451 in treated mESCs, pCDH-empty treated mESCs  and 
untreated mESCs
CFU-ECFU-GMCFU-GEMMColonies
Groups
26 ± 2.3712 ± 2.81 20 ± 2.34Mir-451 in treated mESCs
6 ± 1.3617 ± 1.411 8 ± 1.21pCDH-empty in treated mESCs 
5 ± 1.2818 ± 1.1917 ± 1.01Untreated mESCs
mESCs; Murine embryonic stem cells, CFU-GEMM; Colony-forming unit-granulocyte, erythroid, macrophage, 
megakaryocyte, CFU-GM; CFU-granulocyte, macrophage and CFU-E; CFU-erythroid.
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Fig.7: Overexpression of TER-119 in murine embryonic stem cells (mESCs). More than 95% of cells were gated in R1. A. FACS histogram 
showing transduction efficiency of mESCs with lentiviral vector expressing pCDH-Mir-451, B. FACS histogram showing transduction effi-
ciency of mESCs with lentiviral vector expressing pCDH-empty vector and C. FACS histogram showing transduction efficiency of untreated 
mESCs. The positive regions were adjusted according to the control isotope antibody reaction.
A
B
C
 CELL JOURNAL(Yakhteh), Vol 18, No 2, Jul-Sep (Summer) 2016 174
The Ef fect of Mir-451 Upregulation
Fig.8: Overexpression of CD235a in murine embryonic stem cells (mESCs). More than 95% of cells were gated in R1. A. FACS histogram 
showing transduction efficiency of mESCs with lentiviral vector expressing pCDH-Mir-451, B. FACS histogram showing transduction effi-
ciency of mESCs with lentiviral vector expressing pCDH-empty vector and C. FACS histogram showing transduction efficiency of untreated 
mESCs. The positive regions were adjusted according to the control isotope antibody reaction.
A
B
C
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Fig.9: CFC assay of murine embryonic stem cells (mESCs), A. CFU-E, 
B. CFU-GEMM and C. CFU-GM with some CFU-E, all observed under 
an inverted microscope (×100) showing that mESCs generated the 
colonies. CFU-E; Colony-forming unit-erythroid, CFU-GEMM; CFU-
granulocyte, erythroid, macrophage, megakaryocyte and CFU-GM; 
CFU-granulocyte, macrophage.
Discussion
Erythropoiesis requires the regulation of several 
pathways to enable the production of vast numbers 
of red blood cells (RBCs) over a person’s lifetime 
(35, 36). The particular biological functions of in-
dividual miRNAs are now appearing through re-
verse genetic studies, revealing important roles in 
development, physiology and disease, including 
hematopoiesis (19, 37). MiRNAs play important 
roles in regulation of a multitude of physiological 
functions, such as stem cell differentiation and de-
velopment. Precise regulation of these processes 
is vital to normal development and prevention of 
cancer. The aim of some large studies was to iden-
tify the roles of miRNAs in differentiation in dif-
ferent organs (38-40) including hematopoietic lin-
eage differentiation (41, 42). MiRNAs, because of 
their small size, nuclease resistance, fast synthesis 
and long half-life/bioactivity may be the ideal sub-
stitutes for growth factors for direct differentiation 
towards any particular cell type (43). Several mu-
rine miRNA loci have recently been disturbed by 
gene targeting with resultant hematopoietic pheno-
types (e.g., mice lacking Mir-155, a lymphoid-re-
stricted miRNA, have defective immune respons-
es) (44). In this study, we found a new protocol to 
differentiate mESCs into erythroid lineage by ex-
pression modulation of specific miRNAs in the ab-
sence of any erythroid-specific cytokines. mESCs 
were treated with pCDH-451 lentiviruses and the 
emergence of erythroid lineage was investigated. 
In our EB differentiation system, overexpression 
of Mir-451 in mESCs induced the differentiation 
of erythroid cells. Our observation seems to be in 
agreement with a previous study by Kouhkan et al. 
(45) who demonstrated that Mir-451 have a strong 
positive correlation with the appearance of eryth-
roid specific cell surface markers such as CD71 
and CD235a, and hemoglobin synthesis upon 
erythroid differentiation of CD133+ cells and Pase 
et al. (26) also showed that Mir-451 accelerated 
the rate of erythrocyte maturation, an action medi-
ated in part by repression of gata2.In addition, they 
showed  that Mir-451 is significantly up-regulated 
during erythroid differentiation. Mir-451 plays an 
important role in promoting erythroid maturation, 
in part via its target GATA-2.
As markers of erythropoiesis, we examined the 
expression of Gata-1, Epor, and Klf-1 transcrip-
tion factors using qRT-PCR in all groups. Re-
A
B
C
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sults revealed that these factors were expressed 
in mESCs transduced with lentiviral vector ex-
pressing pCDH-Mir-451. Gata-1 expression was 
decreased in all groups on day 21. Gata-1 reveals 
physiologically that occur during normal eryth-
ropoiesis (46). During transcriptional effects or 
physical interactions with core cell cycle com-
ponents, Gata-1 could obstruct cell proliferation 
(47). Rylski et al. (47) showed that Gata-1 per-
suades G1 arrest during erythroid maturation and 
identified an extensive Gata-1-regulated network 
of gene activation and repression related to cell 
cycle control. Epor expression was increased in 
the pCDH-451 group on day 21. Erythropoietin 
(Epo) is a glycoprotein and a major regulator of 
the growth and differentiation of erythroid blood 
cells. Its biological influence is mediated through 
binding to the Epor on the cell surface (48). Klf-
1 expression was decreased in all groups on day 
21. Cantor and Orkin (49) have shown that binding 
sites for both Klf-1 (and the related ubiquitously 
expressed protein Sp1) and Gata-1 are located 
in close proximity in cis-regulatory elements of 
erythroid-specific genes. In addition, both Sp1 and 
Klf-1 physically associate with the zinc finger re-
gion of Gata-1 and synergistically activate Gata-1 
target genes in transiently expressed reporter con-
structs. Thus, protein-protein interactions between 
Gata-1 and Klf-1 may be implicated in facilitating 
the switch from fetal to adult globin expression.
An additional study on the expression profile 
of hemoglobin chains using qRT-PCR indicated 
that the up-regulation of Mir-451 induced a sig-
nificant rise in mESC hemoglobinization and 
similarly we detected a sharp increase of accu-
mulation of α- globin and β-globin transcripts in 
the pCDH-451 group. Therefore, Mir-451 seems 
to have more effect on the progression of eryth-
roid maturation that increasing expression level 
of α-globin and β-globin. These results are con-
sistent with some previous studies indicating that 
Mir-451 has a strong positive correlation with the 
late stage of erythropoiesis (41, 42, 45, 50, 51). 
On the other hands, Mir-451 stimulated embryonic 
globin chains (ζ and ε) and γ-globin. In the first 
step of erythroid differentiation, expression level 
of γ-globin was at high level and at the late step of 
it, γ-globin expression was low (51). According to 
our results, ζ-globin and ε-globin expression were 
elevated in the pCDH-451 group on day 21. ζ -glo-
bin is an essential globin chain for embryonic Hb 
such as Gower I (ζ2ε2), Portland I (ζ2γ2) and Port-
land II (ζ2β2) (52). In addition, expression level of 
Gata-1 was decreased on day 21. Raich et al. (53) 
showed that Gata-1 obstruct human epsilon globin 
transcription by binding to its proximal promoter. 
In mice, erythropoiesis begins in the embryonic 
yolk sac where primitive erythroid cells express 
εy and bh-1 globins. The εy gene is suppressed in 
definitive erythroid cells. In definitive erythropoie-
sis, ε is expressed and suppressed autonomously, 
however, in primitive erythropoiesis ε seems to be 
regulated competitively (54, 55).
In this study, we isolated mESCs treated with 
pCDH-Mir-451 and confirmed that they display 
stem cell properties based on CFC assays, consist-
ent with similar findings obtained with HSCs (22, 
56). We also isolated mESCs treated with pCDH 
empty vector and untreated mESCs as we con-
trol groups to analyze miRNA expression profile. 
mESCs are a mixed population consisting predom-
inantly, almost 90%, of differentiated, committed 
hematopoietic progenitor cells (HPCs). We com-
pared miRNA expression profiles of these three 
mESCs subpopulations to detect differentially ex-
pressed miRNAs.
We examined the effect of overexpression of Mir-
451 on erythroid differentiation of mESCs. FACS 
results indicated that Mir-451 up-regulation induced 
the erythroid surface markers TER119 and CD235a. 
CD235a expression increased on day 14 and reached 
its peak level on day 21. These results were similar 
to those reported by Choong et al. (57) and Kouh-
kan et al. (45, 51). TER119 expression increased 
upon erythroid differentiation. Kina et al. (58) dem-
onstrated that TER-119 was highly specific to eryth-
roid cells at the stages from early proerythroblast to 
mature erythrocyte and that TER-119 recognizes a 
cell surface molecule which is strongly associated 
with glycophorin A. It was shown that TER-119 was 
expressed only on normal erythroid cells but not on 
erythroleukaemia cells, even after induction of these 
cells with dimethylsulphoxide (DMSO).
Conclusion
We show that Mir-451 up-regulation may play 
important roles in erythroid differentiation for in 
vitro erythropoiesis of mESCs and production of 
artificial RBCs without the presence of any stim-
ulatory cytokines. Since the major problem of pa-
tients with hemoglobinopathies, such as sickle cell 
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anemia and thalassemia, is failure in the production 
of adult globin (HbA) and reactivation of the α- and 
β-globin chains has been shown to rescue the lethal-
ity of mice with α- and β-thalassemia. Mir-451 and 
other miRNAs may be useful in designing effective 
therapeutic strategies for the possibility of reversing 
these abnormalities by gene therapy.
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